SASH1 has been proposed as a tumor suppressor, based on the correlation of the presence of SASH1 mRNA expression with beneficial prognosis in several human cancers2–8,28–31 and the observation that loss or depletion of SASH1 enhances tumor cell line survival and invasiveness in vitro3,5–8. Here, SASH1 is linked to neoplasm.